title: The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients.
authors.affiliation: South Carolina College of Pharmacy - USC Campus, Columbia, SC, USA.
authors.forename: V
authors.initials: V
authors.lastname: Noxon
authors.affiliation: University of South Carolina College of Pharmacy, Columbia, SC, USA.
authors.forename: C
authors.initials: C
authors.lastname: Bennett
authors.affiliation: University of South Carolina, Greenville, SC, USA.
authors.forename: J
authors.initials: J
authors.lastname: Wu